Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
2012
Heavy metals in food crops: Health risks, fate, mechanisms, and management
2019 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Toxicity, mechanism and health effects of some heavy metals
2014 Standout
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
2003
Endochondral bone formation is involved in media calcification in rats and in men
2007
Embryo Implantation
2000 Standout
Spectrum of acute renal failure in the intensive care unit: The PICARD experience
2004
Mechanisms of Vascular Calcification
2007
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Oral Phosphate Binders in Patients with Kidney Failure
2010
Frequency of adynamic bone disease and aluminium storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies
1996
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
2010
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
2007
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
2011
Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients
2001
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Osteocalcin: A non-invasive index of metabolic bone disease in patients treated by CAPD
1994
Long-term fracture risk following renal transplantation: a population-based study
2003
Circulating Osteoprotegerin and Receptor Activator for Nuclear Factor κB Ligand: Clinical Utility in Metabolic Bone Disease Assessment
2005
Mechanisms of renal ischaemic injury and their clinical impact
2005
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
2006
Comparison of the Humoral Markers of Bone Turnover and Bone Mineral Density in Patients on Haemodialysis and Continuous Ambulatory Peritoneal Dialysis
2002
Circulating biochemical markers of bone remodeling in uremic patients
1999
OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
2006
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis
2003
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
Vitamin D Deficiency and Associated Factors in Hemodialysis Patients
2008
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
2000
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
2007
Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study
2007
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort
2007
Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
2003
Vitamin D Receptor Activators Can Protect against Vascular Calcification
2008
Calcification of the Aortic Valve in the Dialyzed Patient
2000
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)
2005
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
VITAMIN D IN HEALTH AND DISEASE: The Evolution of Assays for Parathyroid Hormone
2005
Low Dose CalcitriolVersusPlacebo in Patients with Predialysis Chronic Renal Failure*
1988
Calcium Balance during Hemodialysis
2007
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
2004
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
2008
Survival following parathyroidectomy among United States dialysis patients
2004
Percutaneous bone biopsy in the diagnosis of renal osteodystrophy
2002
Practical considerations in PTH testing
2005
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
2006 Standout
Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients
2006
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up
2006
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Eutrophication management in surface waters using lanthanum modified bentonite: A review
2015
Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients
2005
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D
2006
Calcification and cardiovascular problems in renal failure
2005
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry
2005
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men
1997
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
2006
Biological Markers in the Diagnosis of the Different Forms of Renal Osteodystrophy
2000
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
2008
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography
2001
No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients
1997
Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study
2008
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients
2001 Standout
Vitamin D levels and early mortality among incident hemodialysis patients
2007
Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
1996
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease: An Overview
2005
Osteoprotegerin and bone mineral density in hemodialysis patients
2006
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients
2008
Lanthanum carbonate: a new phosphate binder
2004
Chronic Kidney Disease
2016 Standout
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
2010
Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
2006
Cyanobacterial blooms
2018 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment
2007
Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges
2007
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Assessment of Parathyroid Function in Clinical Practice: Which Parathyroid Hormone Assay Is Better?
2004
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Survival after Parathyroidectomy in Patients with End‐stage Renal Disease and Severe Hyperparathyroidism
2007
Involutional Osteoporosis
1986 Standout
Comparative Accuracy of Renal Duplex Sonographic Parameters in the Diagnosis of Renal Artery Stenosis: Paired and Unpaired Analysis
2007
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Effect of 6-Month Whole Body Vibration Training on Hip Density, Muscle Strength, and Postural Control in Postmenopausal Women: A Randomized Controlled Pilot Study
2004 Standout
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
2008
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
The Tumor Lysis Syndrome
2011 Standout
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis
2004
Role of Vitamin D Deficiency in Chronic Kidney Disease
2007
Calcitonin
1981
Serum Concentrations of Cross-Linked N-Telopeptides of Type I Collagen: New Marker for Bone Resorption in Hemodialysis Patients
2005
Progressive Hypertension in a Patient With “Incidental” Renal Artery Stenosis
2002
Electrochemiluminescence (ECL)
2004 Standout
Transfer of rare earth elements (REE) from natural soil to plant systems: implications for the environmental availability of anthropogenic REE
2012
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
2000 Standout
25-Hydroxyvitamin D Deficiency and Diabetes Predict Reduced BMD in Patients With Chronic Kidney Disease
2006
The Role of Vitamin D in Cancer Prevention
2005 Standout
Bone Mineral Density: Serum Markers of Bone Turnover and Their Relationships in Peritoneal Dialysis
2004
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Vitamin D compounds for people with chronic kidney disease requiring dialysis
2009
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein
1981 StandoutNobel
Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients
1996
Clinical Evaluation of the Elecsys β-CrossLaps Serum Assay, a New Assay for Degradation Products of Type I Collagen C-Telopeptides
2001
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Bone metabolism and disease in chronic kidney disease
2003
Vascular Calcification
2008 Standout
Homologous Radioimmunoassay of Human Osteocalcin
1992
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials
2005
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of G Coen being referenced
Adynamic bone disease: an update and overview.
2005
Serum osteoprotegerin and renal osteodystrophy
2002
Parathyroidectomy in Chronic Renal Failure: Short- and Long-Term Results on Parathyroid Function, Blood Pressure and Anemia
2001
Osteocalcin, iPTH, Alkaline Phosphatase and Hand X-Ray Scores as Predictive Indices of Histomorphometric Parameters in Renal Osteodystrophy
1990
Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate
2001
A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
2003
Deferoxamine Test and PTH Serum Levels Are Useful Not to Recognize but to Exclude Aluminum-Related Bone Disease
1992
Ischemic Nephropathy in an Elderly Nephrologic and Hypertensive Population
1998
Autonomic Neuropathy and Secondary Hyperparathyroidism in Uraemia
1990
Cardiac Calcifications: Fetuin???A and Other Risk Factors in Hemodialysis Patients
2006
Procollagen Type I C-Terminal Extension Peptide in Predialysis Chronic Renal Failure
1992
Procollagen type 1 C-terminal extension peptide, PTH and 1,25(0H)2D3 in chronic renal failure
1993
Renal Osteodystrophy in Predialysis and Hemodialysis Patients: Comparison of Histologic Patterns and Diagnostic Predictivity of Intact PTH
2002
Urinary Deoxypyridinoline Excretion for the Evaluation of Bone Turnover in Chronic Renal Failure
2000
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
1998
ProcoUagen Type 1 C-Terminal Extension Peptide Serum Levels following Parathyroidectomy in Hyperparathyroid Patients
1994
PTH 1-84 and PTH “7-84” in the noninvasive diagnosis of renal bone disease
2002
Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study
1996
Serum leptin in dialysis renal osteodystrophy
2003
Renal Osteodystrophy: α-Heremans Schmid Glycoprotein/Fetuin-A, Matrix GLA Protein Serum Levels, and Bone Histomorphometry
2006
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
2004
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy
2005
Calcitonin and blood calcium homeostasis during intestinal calcium absorption in man
1975
Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment.
1995
Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failure.
1991
Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus
1993
Cardiac Calcium Evaluation in Hemodialysis Patients with Multisection Spiral Computed Tomography
2004
Bone Metabolism and Its Assessment in Renal Failure
1994
Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
1986
Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy
1995
Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up
1985
Fracturing osteoporosis after kidney transplantation--what are the options?
1996
Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels
1984